Hydrochloric Acid → 1-(Tert-butoxycarbonyl)-4-(2-(dimethylamino)ethyl)piperidine-4-carboxylic acid
Reaction equation
[CH3:1][N:2]([CH3:23])[CH2:3][CH2:4][C:5]1([C:18]([O:20]CC)=[O:19])[CH2:10][CH2:9][N:8]([C:11]([O:13][C:14]([CH3:17])([CH3:16])[CH3:15])=[O:12])[CH2:7][CH2:6]1.O.[OH-].[Li+].CCO.Cl>O>[C:14]([O:13][C:11]([N:8]1[CH2:9][CH2:10][C:5]([CH2:4][CH2:3][N:2]([CH3:23])[CH3:1])([C:18]([OH:20])=[O:19])[CH2:6][CH2:7]1)=[O:12])([CH3:17])([CH3:16])[CH3:15]Participants
6
Procedure
1-tert-Butyl 4-ethyl 4-(2-(dimethylamino)ethyl)piperidine-1,4-dicarboxylate from step A (328 mg, 1.0 mmol) was treated overnight with lithium hydroxide monohydrate (210 mg, 5 mmol) in 1:1 EtOH:H2O (5 mL) at 60° C. The reaction was cooled to room temperature, neutralized to pH 6 with 1 N aq. HCl, and concentrated under vacuum. The residue was purified by prep HPLC and lyophilized twice to give the title compound (191 mg, 64%) as a white solid. MS (ES+) [M+H]+=301.
Workup
- customat 60° C
- concentrationconcentrated under vacuum
- customThe residue was purified by prep HPLC
Sources & evidence
- ORD record
- ord-3e83e6bfc9a24a7fa1acf34addaaada1
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08193202B2
Reaction notes
Loading…